Tuesday, 18 Dec 2018

You are here

The RheumNow Week in Review – 6 January 2017

Dr. Jack Cush reviews highlights from the first week of 2017 on RheumNow.com.

Happy New Year!

  1. RheumNow celebrates its 4000th Anniversary Tweet! It all started with the goal to share a pearl, study result, or the answer to test question. Wisdom prevails!
  2. Among 40,000 Dutch, 1% had ACPA+; 22% had RA. ACPA associated with being older, female, joint symptoms, smoking, RA, relatives of RA. https://t.co/8HuCE3XOtU
  3. Big decline in 2016 new drug approvals; 22/2016, (45/2015, 41/2014); 9 were for orphan drugs; 8 were firs in class, the number of new filings is unchanged. (No new drugs for arthritis or Rheumatology. These do not include 3 new TNF biosimilars) https://t.co/ssoGcVqtAF
  4. TNF inhibitor survival in 2687 Finnish patients - 27% discontinue TNFi in 12 mos. Worse with CZP & Remicade, better with combo MTX https://t.co/13vJxWGWCs
  5. Decline in chemokine CXCL4 in MMF Treated patients with improved ILD & scleroderma - epiphenomenal or pathogenic? https://t.co/z9U4FYCHLN
  6. NICE recommends apremilast for use in psoriatic arthritis within UK NHS. Risk of suidical ideation is only 0.2% (3/1441). https://t.co/ZFDSo3B81u
  7. NY Times article says Acthar is "single most expensive drug per patient" costing Medicare $16,2371 per patientst for 3100 Medicare patients treated with Acthar. https://t.co/cskPO7OM1E
  8. CDC Grand Rounds on Chronic Fatigue Syndrome (AKA Myalgic Encephalomyelitis) (ME/CFS) fails to recognize Fibromyalgia as same disease. https://t.co/jem0QpMNxT
  9. Systematic review of >1000 IBD pts treated with biosimilar CT-P13 vs Remicade shows no difference in efficacy, safety, ADAbs https://t.co/BElV5shX03
  10. CDC confirms current influenza vaccines correctly cover strains seen thus far in 2016 and for 2017. Also these strains are senstive to available antiviral Rx (eg, Tamiflu). https://t.co/afag7dq524
  11. Hospira (biosimilar division of Pfizer) began to ship its Inflectra biosimilar to U.S. wholesalers on Nov. 21 & has a sales force in place
  12. Iron deficiency anemia associated with a 2 fold increased risk of sensorineural hearing loss. IDA & SNHL is found in 1.6% of the population. https://t.co/RT77Sjkc4O
  13. Myriad faces loss of Medicare pay for RA VECTRA-DA test, based on recent CMS report. The test is still available. https://t.co/YBx3BqVKeQ
  14. Incident RA prevalence = 0.63%; 2/3 are treated with a DMARD; but 28% were not. How many have never seen a rheumatologist? 38% @1yr & 15% @2yr never seen by Rheumatologist https://t.co/haqDyRAxCN
  15. Weight loss improves Psoriasis. 
  16. Pregnancy Outcomes in Psoriatic Arthritis.
  17. Biopsy Proven Renal Involvement in Sjogren's Syndrome
  18. Modest Benefits with Intraarticular Corticosteroids in Knee Osteoarthritis 
  19. PPI Safety Issues 
  20. A Low Risk of Inflammatory Bowel Disease with IL-17 Inhibition
  21. CHMP Recommend Baricitinib for Approval in Europe 
  22. A Link Between Periodontal Disease and Rheumatoid Arthritis
Disclosures: 
The author has received research/grant financial support on this subject
The author has received compensation as an advisor or consultant on this subject

Rheumatologists' Comments

In regards to the Finnish study on TNF inhibitor survival, I suspect the results would be even more in the USA as many"sero-negative" RA patients who are presumed to have RA or "inflammatory arthritis" (not to mention the ever-growing number of nr-axSpA patients) receive a trial of empiric therapy with biologic biologic agents that don't pan out. As the saying goes, "you see what you know" and there is a lot we still don't know about this group of" RA-look alikes".

More Like This

RheumNow Podcast – Vasculitis and Strange Bedfellows (12.14.18)

Dr. Jack Cush reviews the news from the past week on RheumNow.com. 

RheumNow Podcast – Can RA Be Prevented (12.7.18)

Dr. Jack Cush reviews the news and new journal articles from the past week on RheumNow.com:

Chronic Kidney Disease Increasing in the U.S.A.

JAMA has published the Global Burden of Disease (GBD) study showing that that, from 2002 to 2016, the US burden of chronic kidney disease (CKD) increased, with some states exhibiting more than twice the burden as others. The increase in burden was associated with increased metabolic and dietary risk exposure that manifested in increased probability of death due to diabetic CKD, especially for those between 20 to 55 years.  

RheumNow Podcast – To Needle or Not to Needle (11.30.18)

Dr. Jack Cush updates the news and reports from the past week at RheumNow.com:

Physical Activity Guidelines for Americans

The data are clear and disappointing: despite the well-known health benefits, four out of five US adults are not active physically.  JAMA has published the new US Physical Activity Guidelines for Americans, so that health professionals and policy makers can promote lifestyle changes and awareness of the the health benefits of physical activity.